Close Menu


SUGAR-seq, a single-cell method developed by researchers in Australia, is a first step towards analyzing differences in glycosylation in various cell types.

The researchers focused particularly on genes whose expression changed in the hippocampus of people with Alzheimer's disease.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

Using technology rooted in pharmacogenomics testing for medical cannabis, the firm claims it can predict immune response to SARS-CoV-2 and test biomarkers for pharma.

In Nucleic Acids Research this week: targeted splice sequencing study of myotonic dystrophy, structural variant genotyping tool, and more.

In PLOS this week: transcriptome-wide analysis of autism spectrum disorder, diversity of Staphylococcus from infected joint prosthetics, and more.

Decipher will remain a wholly owned subsidiary of Veracyte, which plans to integrate Decipher's urologic cancer tests on its nCounter platform.

In Genome Biology this week: a database of clinically actionable alterations, alternative splicing patterns in glioblastoma, and more.

Researchers have developed a higher-resolution in situ RNA sequencing method that relies on physically expanding a polymer network that holds the RNA.

In Nature this week: genetic and proteomic data gives Alzheimer's disease development insights, whole-genome doubling could be targeted in cancer, and more.


Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.